Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2021.571 | Early versus Delayed surgery after colonic stent bridging for left sided malignant large bowel obstruction | Dr. HO Man Fung |
| 2021.570 | Primary Flexor Tendon Repair: Hong Kong Experience |
Dr. SIU Ronald Wing Hei 蕭永希 |
| 2021.569 | Exposure to elevated LDL and non-HDL cholesterol levels predicts long-term cardiac death after CABG | Dr. LIM Kevin |
| 2021.568 | A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Bio-naive Participants with Active Psoriatic Arthritis Axial Disease |
Prof. TAM Lai Shan 譚麗珊 |
| 2021.567 | An open-label extension study to investigate the long-term safety, tolerability, and efficacy of rozanolixizumab in study participants with persistent or chronic primary immune thrombocytopenia (ITP) |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2021.566 | A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in patients with non-diabetic chronic kidney disease | Prof. SZETO Cheuk Chun |
| 2021.565 | Physicians’ experiences with Do-not-attempt cardiopulmonary resuscitation (DNACPR) decision-making in Hong Kong: attitudes and communication practices | Dr WONG Wai Tat |
| 2021.564 | Clinical outcomes and prognostic factors of Acute Severe Ulcerative Colitis (ASUC) in Asia | Prof. NG Siew Chien |
| 2021.563 | A Phase 2 Study of Magrolimab Combination Therapy in Patients With Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer |
Prof. YEO Winnie 楊明明教授 |
| 2021.562 | Prediction of Mortality and Diabetes complications by Sonographic Assessment of Medial arterial calcification and Renal Arterial resistive index. |
Dr. LIU Kin Hung 廖健鴻 |
| 2021.561 | Cross-sectional Study of Urine Microbiome in Children with Lupus Nephritis | Dr CHAN Oi Man |
| 2021.560 | Ultrasound-guided Retro Superior Costotransverse Ligament (SCTL) Compartment Block: Description of Sonoanatomy, Technique and Block Dynamics |
Prof KARMAKAR Manoj 高文佳 |
| 2021.559 | The use of NT-proBNP for stratifying risk of cardio-renal complications in Chinese patients with Type 2 diabetes |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2021.558 | A prospective study to assess the diagnostic accuracy of a panel of bacterial gene markers (M3) in predicting colorectal advanced adenoma recurrence |
Dr. LAU Louis Ho Shing 柳浩城 |
| 2021.557 | Global SYMPLICITY Registry (GSR) Denervation Findings in Real World (DEFINE) is referred to as the GSR DEFINE study. |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2021.556 | A phase 2 trial of TAS 102 in recurrent/metastatic nasopharyngeal carcinoma |
Prof. MA Brigette Buig Yue 馬碧如 |
| 2021.555 | Asian Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) True Defibrillation Threshold (DFT) Study (Asian S-ICD True DFT Study) |
Dr. CHAN Joseph Yat Sun 陳日新醫生 |
| 2021.554 | Metagenomic study on the distributive pattern of respiratory virus in the community after the emergence of COVID-19 |
Dr. LEE Shui Shan 李瑞山 |
| 2021.553 | Anti-reflux mucosal ablation (ARMA) for postoperative gastroesophageal reflux after sleeve gastrectomy – a pilot study |
Dr. NG Stephen Ka Kei 吳家琦 |
| 2021.552 | A prospective study on the use of the Versius surgical system in performing robotic surgery. |
Prof. TEOH Jeremy Yuen Chun 張源津 |
| 2021.551 | Feasibility of in-utero hematopoietic stem cell transplantation as a conjunctive treatment during in-utero blood transfusion for hemoglobin Bart’s hydrops fetalis syndrome in Hong Kong |
Prof. LEUNG Tak Yeung 梁德楊 |
| 2021.550 | Gut microbiota in autism spectrum disorder: a 3-year prospective case-control study |
Dr. WONG Wing Ho 黃永旲 |
| 2021.549 | Multiplex platform for non-invasive health monitoring |
Prof. GAO Zhaoli 高兆理 |
| 2021.548 | A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer (VOLGA) |
Dr. TEOH Jeremy Yuen Chun 張源津 |
| 2021.547 | Efficacy of a chatbot to deliver cognitive-behavioral therapy for insomnia in youth: A randomized controlled trial | Dr. LI Man Ho |
| 2021.546 | Wearing face masks during exercise in the heat: Does intensity and physical activity level matter? |
Ms. ZHENG Chen 鄭晨 |
| 2021.544 | Autism Spectrum Disorder in Hong Kong Chinese Children with First Episode Psychosis: A Five- Year Follow-Up Study |
Dr. SHEA Ka Sin 佘嘉倩 |
| 2021.543 | Effects of Multicomponent Lifestyle Intervention for Depression Supported with Digital Health Technologies to Promote Adherence: A Randomized Controlled Trial and a Process Evaluation |
Dr. HO Fiona Yan Yee 何欣儀 |
| 2021.542 | Elucidating the influence of HLA haplotype on patients’ response to immune checkpoint inhibitors in lung cancer patients | Dr. CHEUNG Alvin Ho Kwan |
| 2021.541 | Early detection of cognitive decline by HKVMT and genetic markers | Dr. MA Suk Ling |
| 2021.540 | TUMOR-AGNOSTIC PRECISION IMMUNO-ONCOLOGY AND SOMATIC TARGETING RATIONAL FOR YOU (TAPISTRY) PHASE II PLATFORM TRIAL |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2021.539 | A Randomized, Open-Label, Multicenter Study Investigating AB-729, Nucleos(t)ide Analogue and Pegylated Interferon Alfa-2a Treatment in Subjects with Chronic Hepatitis B Infection |
Dr. YIP Wai Man 葉偉文醫生 |
| 2021.538 | A longitudinal study of the impact of sexual self-concept on sexual functioning and sexual quality of life (QOL) among breast cancer survivors | Ms. CHAN Angela Chung Sze |
| 2021.536 | Fathers' involvement during pregnancy and after childbirth-A qualitative study | Ms. NG SO MAN |
| 2021.535 | An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Marstacimab Prophylaxis in Severe (Coagulation Factor Activity <1%) Hemophilia A Participants With or Without Inhibitors or Moderately Severe to Severe Hemophilia B Participants (Coagulation Factor Activity ≤2%) With or Without Inhibitors |
Dr. LEUNG Wing Kwan 梁永堃 |
| 2021.534 | Low-level Red Light-Low Concentration Atropine for Myopia Progression (LAMP-3) Study |
Dr. YAM Jason Cheuk Sing 任卓昇 |
| 2021.533 | Epidemiological investigation of a multidrug-resistant Acinetobacter baumannii hospital outbreak using Multilocus Sequencing Typing (MLST) | Dr. LEE Lok Hang |
| 2021.532 | Genomic characterization of small-colony variant phenotype in Escherichia coli bacteremia |
Prof. NG Wai Yin 吳煒燕 |
| 2021.531 | Identifying risks of outbreaks in work settings and the implications for control measures | Prof. TSE Lap Ah |
| 2021.530 | Effects of virtual reality based intervention on reducing preoperative anxiety among adult patients undergoing elective surgery: a randomized controlled trial |
Mr. CHIU Pak Lung 趙柏龍 |
| 2021.529 | Building a real-time neurofeedback system to enhance language learning |
Dr. FENG Gangyi 馮剛毅 |
| 2021.528 | A survey on characteristics of patients seeking medical attention due to sports injury | Prof. YUNG Patrick Shu Hang |
| 2021.527 | Lumber epidural blood patch: A robust treatment for intracranial hypotension | Dr. CHAN Danny Tat Ming |
| 2021.526 | Effects and mechanism of a new probiotics formula in preventing weight gain |
Dr. LIANG Jessie Qiaoyi 梁巧儀 |
| 2021.525 | Risk screening for prodromal Parkinson’s disease in elderly using smartphone | Dr. HUANG Bei |
| 2021.524 | Establishing high-accuracy blood microbiome biomarkers for colorectal neoplasms diagnosis |
Prof. NG Simon Siu Man 吳兆文 |
| 2021.523 | A Predict-to-Prescribe Approach to Social Communication Treatment in Chinese Preschool Children with Autism Spectrum Disorder |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2021.522 | Aveir Dual-Chamber Leadless i2i IDE Study |
Dr. CHAN Gary Chin Pang 陳展鵬 |
| 2021.521 | A Randomized, Open-Label, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral BCX9930 Monotherapy for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Subjects with Inadequate Response to C5 Inhibitor Therapy |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2021.520 | Patterns of SARS-CoV-2 immunity at household level and their changes over time |
Dr. LEE Shui Shan 李瑞山 |
Page 47 of 262.